Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1993-04-07
1994-06-28
Wax, Robert A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530855, 530350, 424550, A61K 3700
Patent
active
053247159
ABSTRACT:
A protein isolated from crude Haementeria officinalis extract which blocks stimulation of platelet aggregation by collagen. The protein has a molecular weight of approximately 16,000. A method of isolating the protein and using the protein to prevent or delay blood coagulation by blocking the stimulation of platelet aggregation by collagen is also described. The protein is useful in the prevention, prophylaxis, therapy and treatment of thrombotic diseases.
REFERENCES:
patent: 4832849 (1989-05-01), Cardin et al.
Gasic et al., Proc. Am. Assoc. Cancer Res., 27:66 Abstract #261 (1987).
Gasic et al., Cancer Res. 43 pp. 1633-1636 (1983).
Gasic et al., Cancer Res. 44 pp. 5670-5676 (1984).
Tuszynski et al., J. Biol. Chem. 262(20) pp. 9718-9723 (1987).
Han, et al. Gene 75 pp. 47-57 (1989).
Baskova et al. Chem. Abs. 107 No. 23 p. 33 (1987).
Thacker, 69 USPQ 126 (1946).
Connolly Thomas M.
Keller Paul M.
Matukaitis Paul D.
Merck & Co. , Inc.
Parr Richard S.
Schmickel David B.
Wax Robert A.
LandOfFree
Protein for inhibiting collagen-stimulated platelet aggregation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protein for inhibiting collagen-stimulated platelet aggregation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protein for inhibiting collagen-stimulated platelet aggregation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2377561